Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX

Cohen Joshua B sold 100,000 Amylyx Pharmaceuticals, Inc. shares (Form 4)

Traded Nov 9, 2026 · Filed Nov 12, 2026

On Nov 9, 2026, Cohen Joshua B (Director, Co-Chief Executive Officer) sold 100,000 Amylyx Pharmaceuticals, Inc. shares at an average US$29.84 for US$2.98M under a trading plan, leaving 3,513,123 shares. Filed Nov 12, 2026 (Form 4).

Sold
100,000 shares
Price
US$29.84 average (US$29.39 to US$30.11)
Value
US$2.98M
Holding after
3,513,123 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Co-Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 9, 2026Common StockSale38,105US$29.393,575,018Direct
Nov 9, 2026Common StockSale61,895US$30.113,513,123Direct

Source

Download original · View original at SEC

Related